Mode of action of silver-based perovskite against Gram-negative bacteria
Although silver is known for its antibacterial activity, its exact mode of action remains unclear. In our previous work, we described AgNbO<sub>3</sub> nanoparticles (AgNbO<sub>3</sub> NPs) prepared using a ceramic method, followed by high-energy and low-energy ball-milling processes, which exhibited antimicrobial activity with negligible release of Ag<sup>+</sup> in deionized water. Here, we investigated thoroughly the mode of action of these AgNbO<sub>3</sub> NPs against <i>Escherichia coli</i>. Drastic morphological changes in <i>E. coli</i> were observed after their exposure to AgNbO<sub>3</sub> NPs. In addition to cellular damage, AgNbO<sub>3</sub> NPs induced the production of reactive oxygen species and lipid peroxidation, likely following the release of small amounts of Ag<sup>+</sup>. This was concluded from the characterization of mutants resistant to AgNbO<sub>3</sub> NPs that showed cross-resistance to AgNO<sub>3</sub>, impaired reactive oxygen species production and lipid peroxidation, and harbored a key mutation in a two-component regulatory system regulating an Ag<sup>+</sup> efflux pump. We calculated, however, that the quantity of Ag<sup>+</sup> released from AgNbO<sub>3</sub> NPs is not sufficient by itself to lead to bacterial death. We propose that bacterial contact with the AgNbO<sub>3</sub> NPs in combination with Ag<sup>+</sup> release is necessary for the mode of action of AgNbO<sub>3</sub> NPs.IMPORTANCESilver is known for its antibacterial activity, but its exact mode of action remains unclear. Here, we investigated thoroughly the mode of action of AgNbO<sub>3</sub> nanoparticles against <i>Escherichia coli</i>. Our data suggest that AgNbO<sub>3</sub> nanoparticles have dual effects on the cell and that both are required for its lethal action.
Authors
- Houshang Alamdari (ORCID: https://orcid.org/0000-0003-3045-2182)
- Cyrus Talebpour
- Hossein Salimnia (ORCID: https://orcid.org/0000-0002-8069-5185)
- Philippe Leprohon
- Fereshteh Fani
- Marc Ouellette (ORCID: https://orcid.org/0000-0002-6743-9646)
Institutions
- Wayne State University (US)
- Detroit Medical Center (US)
- Children's Hospital of Michigan (US)
- Centre hospitalier de l'Université Laval (CA)
- Université Laval (CA)
Publication Details
- Journal
- Microbiology Spectrum
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1128/spectrum.01648-24
- Citations
- 1
- Primary Topic
- Nanoparticles: synthesis and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.12
Funders
- Alliance de recherche numérique du Canada
- Canadian Institutes of Health Research